The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates
Haiyan Yang1, Guangcai Duan, Jingyuan Zhu
1Department of Epidemiology, College of Public Health of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Abstract:
The two multiple-antibiotic resistance (Mar) phenotypes (n = 8, respectively) and susceptible isolates (n = 4) of Shigella flexneri from China were characterized involving the efflux pump AcrAB-TolC. The accumulation of ciprofloxacin, acrAB-tolC PCR, and levels of mRNA with northern blots were performed in three groups. Sequencing of acrAB-tolC was performed in selected isolates. An efflux inhibition was performed with Phe-Arg-beta-naphthylamide. The accumulation of ciprofloxacin at steady state in susceptible isolates was significantly higher than that in the two Mar groups (p < 0.05). The level of accumulation in the Mar strains was increased upon the addition of the protonophore carbonyl cyanidem-chlorophenylhydrazone. The expression level of acrA mRNA in the Mar isolates was significantly higher than that in the susceptible isolates (p < 0.05). Mar strain H26 had a single-nucleotide substitution in locus 322(G-->T) of acrA, and Mar 0008 in locus 171(C-->A). The susceptible strain N15 had a base deletion in locus 36 (C) of tolC gene. The role of the inhibitors of efflux pumps was significant in some isolates with the high expression of Mar pump genes. In conclusion, overexpression of acrA gene leads to Mar in clinical isolates of S. flexneri, and ciprofloxacin acquired susceptible to S. flexneri with Phe-Arg-beta-naphthylamide.
Insights
Overexpression of the acrA gene contributes to multiple-antibiotic resistance (Mar) in Shigella flexneri. Efflux pump inhibitors showed potential in restoring ciprofloxacin susceptibility in resistant strains.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Shigella flexneri is a significant cause of bacterial dysentery.
- Multiple-antibiotic resistance (Mar) in bacterial pathogens poses a global health threat.
- The AcrAB-TolC efflux pump system is crucial for multidrug resistance in many Gram-negative bacteria.
Purpose of the Study:
- To investigate the role of the AcrAB-TolC efflux pump in the multiple-antibiotic resistance (Mar) of Shigella flexneri clinical isolates.
- To identify genetic mutations associated with Mar phenotypes in Shigella flexneri.
- To evaluate the efficacy of efflux pump inhibition in overcoming antibiotic resistance.
Main Methods:
- Characterization of Mar and susceptible Shigella flexneri isolates.
- Quantitative PCR and Northern blot analysis to determine acrAB-tolC gene expression levels.
- DNA sequencing of acrAB-tolC genes in selected isolates.
- Ciprofloxacin accumulation assays and efflux inhibition studies using Phe-Arg-beta-naphthylamide.
Main Results:
- Ciprofloxacin accumulation was significantly lower in Mar isolates compared to susceptible isolates.
- The expression of acrA mRNA was significantly higher in Mar isolates.
- Specific mutations in acrA and tolC genes were identified in resistant and susceptible strains, respectively.
- Efflux pump inhibitors demonstrated efficacy in restoring ciprofloxacin susceptibility in some Mar isolates.
Conclusions:
- Overexpression of the acrA gene is a key mechanism driving Mar in clinical Shigella flexneri isolates.
- Acquired resistance to ciprofloxacin can be reversed using efflux pump inhibitors like Phe-Arg-beta-naphthylamide.
- The AcrAB-TolC efflux pump system represents a potential therapeutic target for combating antibiotic resistance in Shigella flexneri.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance
ABC Transporters: Exporter
Bacterial Gastroenteritis


